P2 Economic Evaluation of Exagamglogene Autotemcel (EXA-CEL) Gene-Edited Therapy in Patients with Transfusion-Dependent Beta-Thalassemia
Jun 1, 2023, 00:00
10.1016/j.jval.2023.03.015
https://www.valueinhealthjournal.com/article/S1098-3015(23)00115-8/fulltext
Title :
P2 Economic Evaluation of Exagamglogene Autotemcel (EXA-CEL) Gene-Edited Therapy in Patients with Transfusion-Dependent Beta-Thalassemia
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(23)00115-8&doi=10.1016/j.jval.2023.03.015
First page :
Section Title :
Open access? :
No
Section Order :
10008